Morphosys AG - ADR

NASDAQ:MOR  
17.98
-0.07 (-0.39%)
5:53:32 PM EDT: $17.89 -0.09 (-0.50%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.71B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$60.28 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$18.03
50-Day MA$17.86
200-Day MA$10.53
See more pivots

Morphosys AG - ADR Stock, NASDAQ:MOR

Semmelweisstrasse 7, Semmelweisstrasse 7, Planegg, Bayern (Bavaria) 82152
Germany
Phone: +49.89.89927.0
Number of Employees: 564
http://www.morphosys.de

Description

MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.